We hope that the obtained models and information may help to provide an insight into the interaction mechanism of MCHR1 antagonists and facilitate the design and optimization of novel antagonists as anti-obesity agents. The gene discussed is MCHR1; the disease is obesity due to melanocortin 4 receptor deficiency.